https://doi.org/10.1055/a-1524-6918
Pleus S, Kaiser P, Haug C Glukosemessmethoden und ihr Einsatz, Qualitätssicherung und rechtliche Rahmenbedingungen bei Laboranalyse-, POCT- und CGM-Systemen Diabetes aktuell 2021; 19: 8–13
https://doi.org/10.1055/a-1296-1349
Freckmann G, Buck S, Waldenmaier D, Haug C Methoden der Stoffwechselkontrolle – HbA1c versus „time in range“ Diabetologe 2021;17:223–234
Freckmann G, Baumstark A, Hinzmann R, Haug C, Pleus S. Comment on "Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory" by Spanou and Makris J Diabetes Sci Technol. 2021 May 30:19322968211014215.
https://doi.org/10.1177/2F19322968211014215
Buck S, Krauss C, Waldenmaier D, Liebing C, Jendrike N, Högel J, Pfeiffer BM, Haug C, Freckmann G. Evaluation of Meal Carbohydrate Counting Errors in Patients with Type 1 Diabetes Exp Clin Endocrinol Diabetes. 2021 May 25.
https://doi.org/10.1055/a-1493-2324
Ziegler R, Oliver N, Waldenmaier D, Mende J, Haug C, Freckmann G. Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion Diabetes Technol Ther. 2021 May;23(5):350-357.
https://doi.org/10.1089/dia.2020.0525
Freckmann G, Nichols JH, Hinzmann R, Klonoff DC, Ju Y, Diem P, Makris K, Slingerland RJ. Standardization process of continuous glucose monitoring: Traceability and performance Clin Chim Acta. 2021 Apr;515:5-12.
https://doi.org/10.1016/j.cca.2020.12.025
Waldenmaier D, Freckmann G, Pleus S, Hermanns N, Ehrmann D, Heinemann L, Haug C. Therapy adjustments in people with type 1 diabetes with impaired hypoglycemia awareness on multiple daily injections using real-time continuous glucose monitoring: a mechanistic analysis of the HypoDE study BMJ Open Diabetes Res Care. 2021 Apr;9(1):e001848.
https://doi.org/10.1136/bmjdrc-2020-001848
Freckmann G, Mende J, Pleus S, Waldenmaier D, Baumstark A, Jendrike N, Haug C. Mean Absolute Relative Difference of Blood Glucose Monitoring Systems and Relationship to ISO 15197 J Diabetes Sci Technol. 2021 Mar 24:19322968211001402.
https://doi.org/10.1177/2F19322968211001402
Baumstark A, Mende J, Uchiyama J, Haug C, Freckmann G. Description of a Novel Patch Pump for Insulin Delivery and Comparative Accuracy Evaluation J Diabetes Sci Technol. 2021 Mar 19:19322968211000441.
https://doi.org/10.1177/19322968211000441
Schlüter S, Freckmann G, Heinemann L, Wintergerst P, Lange K. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: A real-world multicentre prospective study in 120 adults with type 1 diabetes Diabet Med. 2021 Feb;38(2):e14467.
https://doi.org/10.1111/dme.14467
Petersen B, Vesper I, Pachwald B, Dagenbach N, Buck S, Waldenmaier D, Heinemann L. Diabetes management intervention studies: lessons learned from two studies Trials. 2021 Jan 18;22(1):61.
https://doi.org/10.1186/s13063-020-05017-3
Pleus S, Schauer S, Jendrike N, Zschornack E, Link M, Hepp KD, Haug C, Freckmann G. Proof of Concept for a New Raman-Based Prototype for Noninvasive Glucose Monitoring J Diabetes Sci Technol. 2021 Jan;15(1):11-18.
https://doi.org/10.1177/1932296820947112
Pleus S, Stuhr A, Link M, Haug C, Freckmann G. Variation of Mean Absolute Relative Differences of Continuous Glucose Monitoring Systems Throughout the Day J Diabetes Sci Technol. 2021 Feb 20:1932296821992373.
https://doi.org/10.1177/1932296821992373
Heinemann L, Nagel-Reuper C, Adamczewski, Freckmann G Diagnostik des Gestationsdiabetes mellitus in der Praxis Diabetes aktuell 2020; 18: 329–335
Tytko A, Schlüter S, Freckman G Diabetesdiagnostik in der Praxis Diabetes aktuell 2020; 18: 316–322
Thomas A, Kolassa R Messwertunterschiede und Messgenauigkeit von Systemen zum kontinuierlichen Glukosemonitoring Diabetes aktuell 2020; 18: 336–341
Baumstark A, Jendrike N Blutzuckerselbstmessung – wie kann ein korrekter Wert erzielt werden? Diabetes aktuell 2020; 18: 323–327
Nauck M, Gerdes C, Petersmann A, Müller-Wieland D, Müller U, Freckmann G, Heinemann L, Schleicher E, Landgraf R Definition, Klassifikation und Diagnostik des Diabetes mellitus*:Update 2020 Diabetologie 2020; 15 (Suppl 1): S9–S17
Kulzer B, Anderten H, Borck A, Freckmann G Verbesserung der Blutzuckereinstellung und des Empowerments bei Patienten mit Diabetes durch Selbstkontrolle des HbA1-Werts - eine nicht interventionelle Studie Diab Stoffw Herz 2020;29(1): 9-14
Blödt S, Brüggemann M, Freckmann G, Haase D, Heinemann L, Hoffmüller P, Hunfeld K, Klar E, Meisel C, Müller C, Nothacker M, Rabenaus H, Sachs U, Spitzenberger, F Stenzinger A, Vogeser M, Weichert W, Weinstock C, Zimmermann S Europäische Verordnung über In-vitro-Diagnostika (IVDR) – Hinweis der Sektion „In-vitro-Diagnostik (IVD)“ der Ad-hoc-Kommission „Bewertung von Medizinprodukten“ der AWMF an alle Ärzte, die Labordiagnostik betreiben GMS Zeitschrift zur Förderung der Qualitätssicherung in medizinischen Laboratorien. 2020;11, ISSN 1869-4241
https://dx.doi.org/10.3205/lab000038
Buck S, Zschornack E, Waldenmaier D, Link M, Jendrike N, Obstfelder I, Kamann S, Haug C, Freckmann G. Befundbogen für eine standardisierte Erfassung von Hautreaktionen durch Medizinprodukte für das Diabetes-Management Diabetologie und Stoffwechsel 2021; 16(S 01): S6
https://doi.org/10.1055/s-0041-1727307
Befundbogen_Hautreaktionen (deutsch) und Befundbogen_Hautreaktionen (englisch)
Buck S, Waldenmaier D, Haug C, Freckmann G, Rendschmidt T, Künsting T Entwicklung einer neuen Patch-Pumpe für die Insulintherapie Diab Stoffw Herz 2020;29(3):159-163
Pleus S, Jendrike N, KameckeU, Baumstark A, Liebing C, Freckmann G Messgenauigkeit zweier in der diabetologischen Praxis verwendeten POCT-Glukose-Messsysteme Diab Stoffw Herz 2020;29(2):85-95
Pleus S, Freckmann G, Baumstark A, Haug C. Stability of Glucose Concentrations in Frozen Plasma J Diabetes Sci Technol. 2020 Oct 9:1932296820963657.
https://doi.org/10.1177/2F1932296820963657
Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, Lohnes S, Nichols JH, Spanakis EK, Espinoza J, Palermo NE, Awadjie DG, Bak L, Buckingham B, Cook CB, Freckmann G, Heinemann L, Hovorka R, Mathioudakis N, Newman T, O'Neal DN, Rickert M, Sacks DB, Seley JJ, W Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline J Diabetes Sci Technol. 2020 Nov;14(6):1035-1064.
https://doi.org/10.1177/1932296820954163
Freckmann G, Baumstark A, Jendrike N, Mende J, Schauer S, Link M, Pleus S, Haug C. Impact of Two Different Reference Measurement Procedures on Apparent System Accuracy of 18 CE-Marked Current-Generation Blood Glucose Monitoring Systems J Diabetes Sci Technol. 2020 Aug 19:1932296820948873.
https://doi.org/10.1177/1932296820948873
Kress S, Anderten H, Borck A, Freckmann G, Heinemann L, Holzmüller U, Kulzer B, Portele A, Schnell O, Varlemann H, Zemmrich C, Lobmann R. Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score J Diabetes Sci Technol. 2020 Jun 10:1932296820922592.
https://doi.org/10.1177/2F1932296820922592
Pleus S, Kamecke U, Waldenmaier D, Link M, Zschornack E, Jendrike N, Haug C, Freckmann G. Time in Specific Glucose Ranges, Glucose Management Indicator, and Glycemic Variability: Impact of Continuous Glucose Monitoring (CGM) System Model and Sensor on CGM Metrics J Diabetes Sci Technol. 2020 Jun 8:1932296820931825.
https://doi.org/10.1177/1932296820931825
Freckmann G, Buck S, Waldenmaier D, et al. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies [published online ahead of print, 2020 Jun 1]. J Diabetes Sci Technol. 2020;1932296820928100.https://doi:10.1177/1932296820928100
Freckmann, G. (2020). Basics and use of continuous glucose monitoring (CGM) in diabetes therapy, Journal of Laboratory Medicine, 44(2), 71-79.
https://doi.org/10.1515/labmed-2019-0189
Waldenmaier D, Zschornack E, Buhr A, Pleus S, Haug C, Freckmann G. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control. Diabetes Technol Ther. 2020 Apr 6. doi: 10.1089/dia.2019.0445. [Epub ahead of print]
https://doi.org/10.1089/dia.2019.0445
Freckmann G, Buck S, Waldenmaier D, et al. Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management [published online ahead of print, 2020 Mar 22]. J Diabetes Sci Technol. 2020;1932296820911105.
https://doi.org/10.1177/1932296820911105
Befundbogen_Hautreaktionen (deutsch) und Befundbogen_Hautreaktionen (englisch)
Han J, Heinemann L, Ginsberg BH, Alva S, Appel M, Bess S, Chen KY, Freckmann G, Harris DR, Hartwig M, Hinzmann R, Kerr D, Krouwer J, Morrow L, Nichols J, Pfützner A, Pleus S, Rice M, Sacks DB, Schlueter K, Vesper HW, Klonoff DC. The YSI 2300 Analyzer Replacement Meeting Report. J Diabetes Sci Technol. 2020 Mar 16:1932296820911471. doi: 10.1177/1932296820911471. [Epub ahead of print]
https://doi.org/10.1177/1932296820911471
Ulbrich S, Waldenmaier D, Haug C, Freckmann G, Rendschmidt T, Künsting T. Concept and Implementation of a Novel Patch Pump for Insulin Delivery. J Diabetes Sci Technol. 2020 Mar;14(2):324-327. doi: 10.1177/1932296819871626. Epub 2019 Aug 27.
https://doi.org/10.1177/1932296819871626
Baumstark A, Jendrike N, Kamecke U, Liebing C, Pleus S, Freckmann G. Measurement accuracy of two professional-use systems for point-of-care testing of blood glucose. Clin Chem Lab Med. 2020 Feb 25;58(3):445-455. doi: 10.1515/cclm-2019-0549.
https://doi.org/10.1515/cclm-2019-0549
Ziegler R, Heinemann L, Freckmann G, Schnell O, Hinzmann R, Kulzer B. Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM. J Diabetes Sci Technol. 2020 Feb 17:1932296820905577. doi: 10.1177/1932296820905577. [Epub ahead of print]
https://doi.org/10.1177/1932296820905577
Ziegler R, Waldenmaier D, Kamecke U, Mende J, Haug C, Freckmann G. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents. Pediatr Diabetes. 2020 Jan 31. doi: 10.1111/pedi.12993. [Epub ahead of print]
https://doi.org/10.1111/pedi.12993
Pleus S, Baumstark A, Jendrike N, Mende J, Link M, Zschornack E, Haug C, Freckmann G. System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015. BMJ Open Diabetes Res Care. 2020 Jan;8(1). pii: e001067. doi: 10.1136/bmjdrc-2019-001067.
http://dx.doi.org/10.1136/bmjdrc-2019-001067
Oliver N, Gimenez M, Calhoun P, Cohen N, Moscardo V, Hermanns N, Freckmann G, Reddy M, Heinemann L. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia. Diabetes Care. 2020 Jan;43(1):53-58. doi: 10.2337/dc19-0977. Epub 2019 Sep 17.
https://doi.org/10.2337/dc19-0977
Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, Hinzmann R, Kassab A, Freckmann G, Reiterer F, Del Re L. Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space. J Diabetes Sci Technol. 2020 Jan;14(1):135-150. doi: 10.1177/1932296819855670. Epub 2019 Jun 19.
https://doi.org/10.1177/1932296819855670
Link M, Kamecke U, Waldenmaier D, Pleus S, Garcia A, Haug C, Freckmann G. Comparative Accuracy Analysis of a Real-time and an Intermittent-Scanning Continuous Glucose Monitoring System. J Diabetes Sci Technol. 2019 Dec 17:1932296819895022. doi: 10.1177/1932296819895022. [Epub ahead of print]
https://doi.org/10.1177/1932296819895022
Heinemann L, Deiss D, Siegmund T, Schlüter S, Naudorf M, Sengbusch SV, Lange K, Freckmann G. Glucose Measurement and Control in Patients with Type 1 or Type 2 Diabetes. Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S8-S26. doi: 10.1055/a-1018-9090. Epub 2019 Dec 20.
https://doi.org/10.1055/a-1018-9090
Petersmann A, Müller-Wieland D, Müller UA, Landgraf R, Nauck M, Freckmann G, Heinemann L, Schleicher E. Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2019 Dec;127(S 01):S1-S7. doi: 10.1055/a-1018-9078. Epub 2019 Dec 20.
https://doi.org/10.1055/a-1018-9078
Heinemann L, Freckmann G, Müller-Wieland D, Kellerer M. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin? J Diabetes Sci Technol. 2019 Nov 1:1932296819883885. doi: 10.1177/1932296819883885. [Epub ahead of print]
https://doi.org/10.1177/1932296819883885
Baumstark A, Pleus S, Jendrike N, Liebing C, Hinzmann R, Haug C, Freckmann G. Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements. J Diabetes Sci Technol. 2019 Nov;13(6):1105-1111. doi: 10.1177/1932296819833369. Epub 2019 Mar 6.
https://doi.org/10.1177/1932296819833369
Pleus S, Ulbrich S, Zschornack E, Kamann S, Haug C, Freckmann G. Documentation of Skin-Related Issues Associated with Continuous Glucose Monitoring Use in the Scientific Literature. Diabetes Technol Ther. 2019 Oct;21(10):538-545. doi: 10.1089/dia.2019.0171. Epub 2019 Jul 25.
https://doi.org/10.1089/dia.2019.0171
Befundbogen_Hautreaktionen (deutsch) und Befundbogen_Hautreaktionen (englisch)
Freckmann G, Link M, Kamecke U, Haug C, Baumgartner B, Weitgasser R. Performance and Usability of Three Systems for Continuous Glucose Monitoring in Direct Comparison. J Diabetes Sci Technol. 2019 Sep;13(5):890-898. doi: 10.1177/1932296819826965. Epub 2019 Feb 7.
https://doi.org/10.1177/1932296819826965
Baumstark A, Pleus S, Jendrike N, Liebing C, Hinzmann R, Haug C, et al.: Proof of Concept Study to Assess the Influence of Oxygen Partial Pressure in Capillary Blood on SMBG Measurements. J Diabetes Sci Technol 2019:1932296819833369.https://doi.org/10.1177/1932296819833369
Jendrike N, Baumstark A, Pleus S, Mende J, Haug C, Freckmann G.: Assessment of System Accuracy, Intermediate Measurement Precision, and Measurement Repeatability of a Blood Glucose Monitoring System Based on ISO 15197. J Diabetes Sci Technol 2019;13(2):235-241.
https://doi.org/10.1177/1932296818821105
Jendrike N, Baumstark A, Pleus S, Liebing C, Kamecke U, Haug C, et al.: Accuracy of Five Systems for Self-Monitoring of Blood Glucose in the Hands of Adult Lay-Users and Professionals Applying ISO 15197:2013 Accuracy Criteria and Potential Insulin Dosing Errors. Curr Med Res Opin 2019;35(2):301-311.
https://doi.org/10.1080/03007995.2018.1491832
Pleus S, Kamecke U, Waldenmaier D, Freckmann G.: Reporting Insulin Pump Accuracy: Trumpet Curves According to IEC 60601-2-24 and Beyond. J Diabetes Sci Technol 2019;13(3):592-596.
https://doi.org/10.1177/1932296818806509
Freckmann G, Pleus S, Grady M, Setford S, Levy B.: Measures of Accuracy for Continuous Glucose Monitoring and Blood Glucose Monitoring Devices. J Diabetes Sci Technol 2019;13(3):575-583.
https://doi.org/10.1177/1932296818812062
Heinemann L, Waldenmaier D, Kulzer B, Ziegler R, Ginsberg B, Freckmann G.: Patch Pumps: Are They All the Same? J Diabetes Sci Technol 2019;13(1):34-40.
https://doi.org/10.1177/1932296818795150
Kamecke U, Waldenmaier D, Haug C, Ziegler R, Freckmann G.: Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps. J Diabetes Sci Technol 2019;13(1):60–67.
https://doi.org/10.1177/1932296818788349
Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, Hinzmann R, Kassab A, Freckmann G, et al.: Benefits and Limitations of MARD as a Performance Parameter for Continuous Glucose Monitoring in the Interstitial Space. J Diabetes Sci Technol 2019:1932296819855670.
https://doi.org/10.1177/1932296819855670
Hermanns N, Heinemann L, Freckmann G, Waldenmaier D, Ehrmann D.: Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the Hypode Study. J Diabetes Sci Technol 2019;13(4):636-644.
https://doi.org/10.1177/1932296819831695
Pleus S, Kamecke U, Link M, Haug C, Freckmann G.: Flash Glucose Monitoring: Differences between Intermittently Scanned and Continuously Stored Data. J Diabetes Sci Technol 2018;12(2):397-400.
https://doi.org/10.1177/1932296817733095
Waldenmaier D, Schollkopf K, Westhoff A, Heinemann L, Freckmann G.: Comparative Handling Analysis of Different Insulin Pump Systems. J Diabetes Sci Technol 2018;12(2):401-406.
https://doi.org/10.1177/1932296817729391
Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, et al.: Hba1c-Messung in Deutschland: Ist Die Qualität Ausreichend Für Verlaufskontrolle Und Diagnose? Diabetologie und Stoffwechsel 2018;13(01):46-53.
Baumstark A, Jendrike N, Pleus S, Liebing C, Haug C, Freckmann G.: Accuracy Evaluation of a New System for Self-Monitoring of Blood Glucose with Three Test Strip Lots Based on ISO 15197:2013. J Diabetes Sci Technol 2018;12(2):539-540.
https://doi.org/10.1177/1932296817730380
Jendrike N, Baumstark A, Pleus S, Liebing C, Beer A, Flacke F, et al.: Evaluation of Four Blood Glucose Monitoring Systems for Self-Testing with Built-in Insulin Dose Advisor Based on ISO 15197:2013: System Accuracy and Hematocrit Influence. Diabetes Technol Ther 2018;20(4):303-313.
https://doi.org/10.1089/dia.2017.0391
Schrangl P, Reiterer F, Heinemann L, Freckmann G, Del Re L.: Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials. Biosensors 2018;8(2):50.
https://doi.org/10.3390/bios8020050
Freckmann G, Link M, Westhoff A, Kamecke U, Pleus S, Haug C.: Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring Systems. Diabetes Technol Ther 2018;20(8):550-556.
https://doi.org/10.1089/dia.2018.0112
Freckmann G, Link M, Pleus S, Westhoff A, Kamecke U, Haug C.: Measurement Performance of Two Continuous Tissue Glucose Monitoring Systems Intended for Replacement of Blood Glucose Monitoring. Diabetes Technol Ther 2018;20(8):541-549.
https://doi.org/10.1089/dia.2018.0105
Heinemann L, Deiss D, Siegmund T, Schluter S, Naudorf M, von Sengbusch S, et al.: Practical Recommendations for Glucose Measurement, Glucose Monitoring and Glucose Control in Patients with Type 1 or Type 2 Diabetes in Germany. Exp Clin Endocrinol Diabetes 2018;126(7):411-428.
https://doi.org/10.1055/a-0586-5302
Freckmann G, Jendrike N, Baumstark A, Pleus S, Liebing C, Haug C.: User Performance Evaluation of Four Blood Glucose Monitoring Systems Applying ISO 15197:2013 Accuracy Criteria and Calculation of Insulin Dosing Errors. Diabetes Therapy 2018;9(2):683-697.
https://doi.org/10.1007/s13300-018-0392-6
Petersmann A, Nauck M, Müller-Wieland D, Kerner W, Müller UA, Landgraf R, et al.: Definition, Classification and Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2018;126(07):406-410.
https://doi.org/10.1055/a-0584-6223
Landgraf R, Nauck M, Freckmann G, Muller UA, Heinemann L, Kellerer M, et al.: [Pitfalls in the Diagnosis of Diabetes: Are We Too Lax with Laboratory Parameters?]. Dtsch Med Wochenschr. 2018 Oct;143(21):1549-1555.
https://doi.org/10.1055/a-0673-2156
Heinemann L, Kaiser P, Freckmann G, Grote-Koska D, Kerner W, Landgraf R, et al.: Higher Hba1c Measurement Quality Standards Are Needed for Follow-up and Diagnosis: Experience and Analyses from Germany. Hormone and metabolic research 2018;
https://doi.org/10.1055/a-0746-4288
Heinemann L, Stuhr A, Brown A, Freckmann G, Breton MD, Russell S, et al.: Self-Measurement of Blood Glucose and Continuous Glucose Monitoring - Is There Only One Future? Eur Endocrinol 2018;14(2):24-29.
https://doi.org/10.17925/EE.2018.14.2.24
Freckmann G, Mende J.: Continuous Glucose Monitoring: Data Management and Evaluation by Patients and Health Care Professionals – Current Situation and Developments. LaboratoriumsMedizin 2018;42(6):225-233.
http://doi.org/10.1515/labmed-2018-0119
Pleus S, Jendrike N, Baumstark A, Mende J, Haug C, Freckmann G.: Evaluation of Analytical Performance of Three Blood Glucose Monitoring Systems: System Accuracy, Measurement Repeatability, and Intermediate Measurement Precision. J Diabetes Sci Technol 2018;13(1):111–117.
https://doi.org/10.1177/1932296818804837
Waldenmaier D, Zschornack E, Kalt L, Buhr A, Pleus S, Haug C, et al.: First User Experiences with a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients with Type 1 Diabetes Experienced in Insulin Pump Therapy. J Diabetes Sci Technol 2018;13(1):96–102.
https://doi.org/10.1177/1932296818785386
Ehrmann D, Heinemann L, Freckmann G, Waldenmaier D, Faber-Heinemann G, Hermanns N: The Effects and Effect Sizes of Real-Time Continuous Glucose Monitoring on Patient-Reported Outcomes: A Secondary Analysis of the HypoDE Study. Diabetes Technology & Therapeutics 2019 21:2, 86-93
https://doi.org/10.1089/dia.2018.0332
Baumstark A, Liebing C, Jendrike N, Pleus S, Haug C, Freckmann G: Evaluation of Hematocrit Influence on Measurements With a Novel Self-Monitoring of Blood Glucose System Based on ISO 15197:2013. J Diabetes Sci Technol. 2018;12(5):1078–1079.
https://doi:10.1177/1932296818774813
Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D, Hermanns M: Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. The Lancet (2018).
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30297-6/fulltext
Pleus S, Heinemann L, Freckmann G: Blood Glucose Monitoring Data Should Be Reported in Detail When Studies About Efficacy of Continuous Glucose Monitoring Systems Are Published. J Diabetes Sci Technol (2018) epub ahead of print
http://journals.sagepub.com/doi/abs/10.1177/1932296817753629?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Baumstark A, Jendrike N, Liebing C, Haug C, Freckmann G: System Accuracy and User Performance Evaluation of an Improved System for Self-Monitoring of Blood Glucose. J Diabetes Sci Technol (2018) epub ahead of print
http://journals.sagepub.com/doi/abs/10.1177/1932296817752958?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Freckmann G, Kamecke U, Waldenmaier D, Haug C, Ziegler R: Occlusion Detection Time in Insulin Pumps at Two Different Basal Rates. J Diabetes Sci Technol (2018) epub ahead of print
http://journals.sagepub.com/doi/abs/10.1177/1932296817750404?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Nauck M, Petersmann A, Müller-Wieland D, Kerner W, Müller U A, Landgraf R, Freckmann G, Heinemann L: Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie (2017) 12 (Suppl 2):94-100
Heinemann L, Deiss D, Siegmund T, Schlüter S, Naudorf M, von Sengbusch S, Lange K, Freckmann G: Praxisempfehlung der DDG: Glukosemessung und -kontrolle bei Patienten mit Typ-1- oder Typ-2-Diabetes. Diabetologie (2017) 12 (Suppl 2):242-262
https://doi.org/10.1055/s-0043-119049
Freckmann G: HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle?. J Lab Med 2017; 41(5): 263–267
https://www.degruyter.com/view/j/labm.2017.41.issue-5/labmed-2017-0089/labmed-2017-0089.xml
Sieber J, Flacke F, Link M, Haug C, Freckmann G: Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open- Label, Multicenter, Observational. Diabetes Ther (2017) 8:1079–1085
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630561/pdf/13300_2017_Article_306.pdf
Jendrike N, Baumstark A, Kamecke U, Haug C, Freckmann G: ISO 15197: 2013 Evaluation of a Blood Glucose Monitoring System’s Measurement Accuracy. J Diabetes Sci Technol (2017) 11(6):1275-1276
http://journals.sagepub.com/doi/abs/10.1177/1932296817727550?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Baumstark A, Jendrike N, Pleus S, Haug C, Freckmann G: Evaluation of Accuracy of Six Blood Glucose Monitoring Systems and Modeling of Possibly Related Insulin Dosing Errors. Diabetes Technol Ther (2017) 19(10):580-588
http://online.liebertpub.com/doi/10.1089/dia.2016.0408
Freckmann G, Schlüter S, Heinemann L: Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View. J Diabetes Sci Technol (2017) 11(4): 653–656
http://journals.sagepub.com/doi/abs/10.1177/1932296817721004?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Thurm U, Gehr B, Holder M, Kulzer B, Lange K, Liebl A, Sahm C, von Sengbusch S, Schlüter S, Siegmund T, Ziegler R, Freckmann G, Heinemann L: Continuous glucose monitoring: A training programme for all age groups. International Diabetes Nursing (2017) 4:26–31
http://www.tandfonline.com/doi/full/10.1080/20573316.2017.1335970
Freckmann G, Baumstark A, Pleus S,: Do the New FDA Guidance Documents Help Improving Performance of Blood Glucose Monitoring Systems Compared With ISO 15197?. J Diabetes Sci Technol (2017) 11(6):1240-1246
http://journals.sagepub.com/doi/abs/10.1177/1932296817713220?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Jendrike N, Baumstark A, Chen C, Rittmeyer D, Haug C, Freckmann G: Introduction of a Novel Smartphone- Coupled Blood Glucose Monitoring System. J Diabetes Sci Technol (2017) 11(6):1231-1233
http://journals.sagepub.com/doi/abs/10.1177/1932296817706594?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Pleus S,Flacke F, Sieber J, Haug C, Freckmann G: Strengths and Limitations of New Approaches for Graphical Presentation of Blood Glucose Monitoring System Accuracy Data. J Diabetes Sci Technol (2017) 11(6):1226-1230
http://journals.sagepub.com/doi/abs/10.1177/1932296817707292?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Klonoff D, Freckmann G, Heinemann L: Insulin Pump Occlusions: For Patients Who Have Been Around the (Infusion) Block. J Diabetes Sci Technol (2017) 11(3):451-454
http://journals.sagepub.com/doi/abs/10.1177/1932296817700545?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Lobmann R, Anderten H, Borck A, Freckmann G, Heinemann L, Holzmüller U, Kress S, Kulzer B, Varlemann H, Martin S: Stellenwert der Neuropathie beim Diabetischen Fußsyndrom. Diabetes, Stoffwechsel und Herz (2017) 26:29-36
http://www.diabetologie-online.de/a/stellenwert-der-neuropathie-beim-diabetischen-fusssyndrom-1809919
Kress S, Anderten H, Borck A, Freckmann G, Heinemann L, Holzmüller U, Kulzer B, Portele A, Schnell O, Varlemann H, Zemmerich C, Lobman R: Präulzeröse Risikosituation beim Diabetischen Fußsyndrom - Vorschlag eines einfachen Scores zur Ulkusprävention. Diabetes, Stoffwechsel und Herz (2017) 26:9-18
http://www.diabetologie-online.de/a/vorschlag-eines-einfachen-scores-zur-ulkuspraevention-1809931
Freckmann G, Schlüter S, Heinemann L: Stellungnahme der AGDT zum Ersatz von Blutglukosemessungen durch Messungen mit Systemen zum kontinuierlichen Real-Time-Glukosemonitoring (rtCGM) oder CGM mit intermittierendem Scannen (iscCGM). Diabetes, Stoffwechsel und Herz (2017) 26:43-46
Freckmann G, Baumstark A, Jendrike N, Rittmeyer D, Pleus S, Haug C: Accuracy Evaluation of Four Blood Glucose Monitoring Systems in the Hands of Intended Users and Trained Personnel Based on ISO 15197 Requirements. Diabetes Technol Ther (2017) 19(4):246-254
http://online.liebertpub.com/doi/10.1089/dia.2016.0341
Kamecke U, Baumstark A, Jendrike N, Haug C, Freckmann G: Accuracy Assessment of an Improved Version of an Established Blood Glucose Monitoring System for Self-Testing Following ISO 15197:2013. J Diabetes Sci Technol (2017) 11(4): 851-853
http://journals.sagepub.com/doi/full/10.1177/1932296816688304
Walsh J, Freckmann G, Roberts R, Heinemann L: Bolus Calculator Safety Mandates a Need for Standards. J Diabetes Sci Technol (2017) 11(1):3-6
http://journals.sagepub.com/doi/abs/10.1177/1932296816685475?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Freckmann G, Pleus S, Heinemann L, Koschinsky T: Regulatorische Defizite bei Medizinprodukten. Der Diabetologe (2016) 12:885
https://www.springermedizin.de/regulatorische-defizite-bei-medizinprodukten/11097726?searchBackButton=true&abEvent=detailLink
Kropff J, Choudhary P, Neupane S, Barnard K, Bain SC, Kapitza C, Forst T, Link M, Dehennis A, DeVries JH: Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. Diabetes Care (2017) 40(1):63-68
http://care.diabetesjournals.org/content/40/1/63.long
Freckmann G, Pleus S: Kontinuierliche Glukosemessung - Eine Vision wird zur Kassenleistung. Trillium Diagnostik (2016) 14(3):168-169
Freckmann G, Arndt S, Fießelmann A, Klausmann G, Pralle K, Künsting T, Petersen B: Randomized Cross-Over Study Comparing Two Infusion Sets for CSII in Daily Life. J Diabetes Sci Technol (2017) 11(2):253-259
http://journals.sagepub.com/doi/abs/10.1177/1932296816667510?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Heinemann L, Drossel D, Freckmann G, Kulzer B: Usability of Medical Devices for Patients With Diabetes Who Are Visually Impaired or Blind. J Diabetes Sci Technol (2016) 10(6):1382-1387
http://dst.sagepub.com/content/10/6/1382.long
Reiterer F, Polterauer P, Schoemaker M, Schmelzeisen-Redecker G, Freckmann G, Heinemann L, del Re L: Significance and Reliability of MARD for the Accuracy of CGM Systems. J Diabetes Sci Technol (2017) 11(1)59-67
http://journals.sagepub.com/doi/abs/10.1177/1932296816662047?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Gehr B, Holder M, Kulzer B, Lange K, Liebl A, Sahm C, von Sengbusch S, Schlüter S, Siegmund T, Thurm U, Ziegler R, Freckmann G, Heinemann L for the SPECTRUM Group: SPECTRUM: A Training and Treatment Program for Continuous Glucose Monitoring for All Age Groups. J Diabetes Sci Technol (2017) 11(2):284-289
http://journals.sagepub.com/doi/abs/10.1177/1932296816661735?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Ziegler R, Freckmann G, Heinemann L: Boluses in Insulin Therapy: A Commentary. J Diabetes Sci Technol (2017) 11(2):165-171
http://journals.sagepub.com/doi/abs/10.1177/1932296816653142?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Erbach M, Freckmann G, Hinzmann R, Kulzer B, Ziegler R, Heinemann L, Schnell O: Interferences and Limitations in Blood Glucose Self-Testing: An Overview of the Current Knowledge. J Diabetes Sci Technol (2016) 10(5):1161-8
http://dst.sagepub.com/content/10/5/1161.long
Freckmann G, Pleus S, Schlüter S, Heinemann L: Comment on ‘‘The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System’’ by Bailey et al.. Diabetes Technol Ther (2016) 18(5):334-335
http://online.liebertpub.com/doi/10.1089/dia.2016.0008
Heinemann L, Deiss D, Hermanns N, Graham C, Kaltheuner M, Liebl A, Freckmann G, Wintergerst P, Price D: HypoDE: Studiendesign und Methodik eines RCT zum Nutzen von Real-Time-CGM. Diabetes Stoffw Herz (2016) 25:9-20
http://www.diabetologie-online.de/a/studiendesign-und-methodik-eines-rct-zum-nutzen-von-real-time-cgm-1753692
Liebing C, Erbach M, Schnell O, Haug C, Freckmann G: Glukosemonitoring mit einem neu entwickelten Sensorsystem: Schritt- und Zeitanalyse. Diabetes Stoffw Herz (2016) 25:21-27
http://www.diabetologie-online.de/a/glukosemonitoring-mit-einem-neu-entwickelten-sensorsystem-schritt-und-zeitanalyse-1753703
Freckmann G: Diabetestechnologie. Was gibt es Neues, was bringt die Zukunft?. Der Allgemeinarzt (2016) 3:4-11
http://www.allgemeinarzt-online.de/a/was-gibt-es-neues-was-bringt-die-zukunft-1752046
Pleus S, Baumstark A, Rittmeyer D, Jendrike N, Haug C, Freckmann G: Performance of two updated blood glucose monitoring systems: An evaluation following ISO 15197:2013. CMRO (2016) 32(5):847-855
http://www.tandfonline.com/doi/abs/10.1185/03007995.2016.1146666?journalCode=icmo20
Freckmann G: 20 Jahre Diabetestechnologie- ein Rückblick. ADBW (2016) 46-49
Freckmann G: Patientensicherheit bei der Blutzuckermessung. Thieme Praxis Report (2016) 8:3
Freckmann G, Pleus S, Link M, Haug C: Accuracy of BG Meters and CGM Systems: Possible Influence Factors for the Glucose Prediction Based on Tissue Glucose Concentrations. Predicition Methods for Blood Glucose Concentration. Springer 2016.
Gehr B, Siegmund T, Holder M, Kulzer B, Lange K, Thurm U, Sahm C, Freckmann G, Liebl A, von Sengbusch S, Ziegler R, Heinemann L: SPECTRUM, das Schulungs- und Behandlungsprogramm zum kontinuierlichen Glukosemonitoring (CGM). Diabetes, Stoffwechsel und Herz (2015):24(6):73-76
http://www.diabetologie-online.de/a/1744889
Kerner W, Freckmann G, Müller UA, Roth J, Schleicher E, Niederau C, Müller-Wieland D, Landgraf R, Heinemann L: Positionspapier der Kommission für Labordiagnostik in der Diabetologie der DGKL und der DDG. Diabetologie (2015)10:329-333
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0041-109081
Stephan P, Schmid C, Freckmann G, Pleus S, Haug C, Müller P: The Rectangle Target Plot: A New Approach to the Graphical Presentation of Accuracy of Systems for Self-Monitoring of Blood Glucose. J Diabetes Sci Technol (2015) 10(1):343-349
http://dst.sagepub.com/content/early/2015/10/09/1932296815612490.long
Schmid C, Baumstark A, Heinemann L, Rutschmann M, Haug C, Freckmann G: Anforderungen an die analytische Leistung von Blutzuckermesssystemen - wesentliche Unterschiede zwischen ISO 15197:2003, ISO 15197:2013 und den FDA-Empfehlungen. Diabetes Stoffw Herz (2015) 24:311-320
http://www.diabetologie-online.de/a/1732944
Baumstark A, Kraft M, Hattemer A, Haug C, Freckmann G: Accuracy Evaluation of an Integrated Blood Glucose Monitoring System With Improved Test Cassettes Following ISO 15197:2013. J Diabetes Sci Technol (2015) 10(2):242-244
http://dst.sagepub.com/content/10/1/242.long
Drossel D, Kulzer B, Freckmann G, Heinemann H: Diabetestechnologie für Patienten mit einer Sehbehinderung und für blinde Patienten. Diabetes Stoffw Herz (2015) 24:321-330
http://www.diabetologie-online.de/a/1732946
Kirchsteiger H, Heinemann L, Freckmann G, Lodwig V, Schmelzeisen-Redeker G, Schoemaker M, del Re L: Performance Comparison of CGM Systems: MARD Values Are Not Always a Reliable Indicator of CGM System Accuracy. J Diabetes Sci Technol (2015) 9(5):1030-1040
http://dst.sagepub.com/content/9/5/1030.long
Heinemann L, Freckmann G: CGM Versus FGM; or, Continuous Glucose Monitoring Is Not Flash Glucose Monitoring. J Diabetes Sci Technol (2015) 9(5):947-950
http://dst.sagepub.com/content/9/5/947.long
Neumaier M, Luppa PB, Koschinsky T, Siegel E, Freckmann G, Heinemann L: Aktualisierte Anforderungen an die Messqualität und Qualitätssicherung (QS) von Point-of-Care-Testing(POCT)-Blutglukose-Messystemen mit Unit-use-Reagenzien, die für die Erstdiagnostik eines manifesten Diabetes in der Schwangerschaft oder eines Gestationsd. Diabetologie (2015) 10:197-199
Heinemann L, Koschinsky T, Kleinwechter H, Freckmann G: Kommt es durch die Verwendung citrathaltiger Blutentnahmeröhrchen zu "artifiziell" mehr Diagnosen eines Gestationsdiabetes?. Diabetes, Stoffwechsel und Herz (2015) 24:279-282
http://www.diabetologie-online.de/a/1726814
Schmelzeisen-Redeker G, Schoemaker M, Kirchsteiger H, Freckmann G, Heinemann L, del Re L: Time Delay of CGM Sensors: Relevance, Causes, and Countermeasures. J Diabetes Sci Technol (2015) 9(5):1006-1015
http://dst.sagepub.com/content/9/5/1006.long
Heinemann L, Zijlstra E, Pleus S, Freckmann G: Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a clinical Point of View. Diabetes Care (2015) Published online July 15, 2015
http://care.diabetesjournals.org/content/38/9/e139.long
Freckmann G, Link M, Schmid C, Pleus S, Baumstark A, Haug C: System Accuracy Evaluation of Different Blood Glucose Monitoring Systems Following ISO 15197:2013 by Using Two Different Comparison Methods. Diabetes Technol Ther (2015) 17(9):635-648
http://online.liebertpub.com/doi/10.1089/dia.2015.0085
Heinemann L, Freckmann G: CGM versus FGM oder: Kontinuierliches Glukosemonitoring ist nicht gleich Flash Glucose Monitoring. Diabetes, Stoffwechsel und Herz (2015) 24: 208-210
Freckmann G, Pleus S, Link M, Baumstark A, Schmid C, Högel J, Haug C: Accuracy Evaluation of Four Blood Glucose Monitoring Systems in Unaltered Blood Samples in the Low Glycemic Range and Blood Samples in the Concentration Range Defined by ISO 15197. Diabetes Technol Ther (2015) 17(9):625-634
http://online.liebertpub.com/doi/10.1089/dia.2015.0043
Kleinwechter H, Heinemann L, Freckmann G: Diagnostik des Gestationsdiabetes
Die Crux liegt bei der Blutentnahme. Deutsches Ärzteblatt. Perspektiven der Diabetologie (2015) 1: 24-26
https://www.aerzteblatt.de/archiv/169312/Diagnostik-des-Gestationsdiabetes-Die-Crux-liegt-bei-der-Blutentnahme
Jendrike N, Rittmeyer D, Pleus S, Baumstark A, Haug C, Freckmann G: ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose. J Diabetes Sci Technol (2015) 9(4):934-935
http://dst.sagepub.com/content/early/2015/04/17/1932296815582223.long
Freckmann G: Neue Technologien in der Diabetologie. Wie weit ist es noch bis zum Closed-loop-System?. Der Internist (2015) 56(5):484-92
http://link.springer.com/article/10.1007%2Fs00108-014-3627-2
Link M, Schmid C, Pleus S, Baumstark A, Rittmeyer D, Haug C, Freckmann G: System Accuracy Evaluation of Four Systems for Self-Monitoring of Blood Glucose Following ISO 15197 Using a Glucose Oxidase and a Hexokinase-Based Comparison Method. J Diabetes Sci Technol (2015) 9(5):1041-1050
http://dst.sagepub.com/content/early/2015/04/09/1932296815580161.long
Freckmann G, Schmid C, Baumstark A, Rutschmann M, Haug C, Heinemann L: Analytical Performance Requirements for Systems for Self-Monitoring of Blood Glucose With Focus on System Accuracy: Relevant Differences Among ISO 15197:2003, ISO 15197:2013, and Current FDA Recommendations. J Diabetes Sci Technol (2015) 9(4):885-894
http://dst.sagepub.com/content/early/2015/04/09/1932296815580160.long
Pleus S, Schoemaker M, Morgenstern K, Schmelzeisen-Redeker G, Haug C, Link M, Zschornack E, Freckmann G: Rate-of-Change Dependence of the Performance of Two CGM Systems During Induced Glucose Swings. J Diabetes Sci Technol (2015) 9(4):801-807
http://dst.sagepub.com/content/early/2015/04/01/1932296815578716.long
Heinemann L, Freckmann G: Quality of HbA1c Measurement in the Practice: The German Perspective. J Diabetes Sci Technol (2015) 9(3):687-695
http://dst.sagepub.com/content/early/2015/02/13/1932296815572254.long
New JP, Ajjan R, Pfeiffer AFH, Freckmann G: Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabetic Medicine (2015) 32:609-617
http://onlinelibrary.wiley.com/doi/10.1111/dme.12713/abstract;jsessionid=6E7496E82E468F5ED6113C90F9E96AD5.f02t02
Ziegler R, Freckmann G, Heinemann L: Genauigkeit von Blutzuckermessgeräten in der Praxis evaluieren: Ist das möglich?. Diabetes, Stoffwechsel und Herz (2014) 23: 345-347
http://www.diabetologie-online.de/a/1685866
Freckmann G, Jendrike N, Pleus S, Buck H, Bousamra S, Galley S, Thukral A, Wagner R, Weinert S, Haug C: Use of Microdialysis-Based Continuous Glucose Monitoring to Drive real-Time Semi-Closed-Loop Insulin Infusion. J Diabetes Sci Technol (2014) 8(6):1074-1080
http://dst.sagepub.com/content/8/6/1074.long
Freckmann G, Pleus S, Baumstark A, Schmid C, Link M, Haug C: Self-Monitoring of Blood Glucose: Impact of Time Delay Between Capillary Blood Sampling and Glucose Measurement. J Diabetes Sci Technol (2014) 8(6):1239-1240
http://dst.sagepub.com/content/8/6/1239.long
Baumstark A, Schmid C, Pleus S, Rittmeyer D, Haug C, Freckmann G: Accuracy Assessment of an Advanced Blood Glucose Monitoring System for Self-testing With Three Reagent System Lots Following ISO 15197:2013. J Diabetes Sci Technol (2014) 8(6):1241-1242
http://dst.sagepub.com/content/8/6/1241.long
Heinemann L, Freckmann G: Qualität der HbA1c-Messung in der Praxis: Ein vernachlässigtes Thema?. Diabetes, Stoffwechsel und Herz (2014) 23: 91-98
http://www.diabetologie-online.de/a/1632518
Pleus S, Schmid C, Link M, Baumstark A, Haug C, Stolberg E, Freckmann G: Accuracy Assessment of Two Novel Systems for Self-Monitoring of Blood Glucose Following ISO 15197:2013. J Diabetes Sci Technol (2014): Vol. 8(4) 906-908
http://dst.sagepub.com/content/8/4/906.long
Freckmann G, Schmid C, Pleus S, Baumstark A, Link M, Stolberg E, Haug C, Sieber J: System accuracy evaluation of systems for point-of-care testing of blood glucose: A comparison of a patient-use system with six professional-use systems. Clin Chem Lab Med (2014) 52(7): 1079-1086
http://www.degruyter.com/view/j/cclm.2014.52.issue-7/cclm-2013-0976/cclm-2013-0976.xml
Link M, Pleus S, Schmid C, Freckmann G, Baumstark A, Stolberg E, Haug C: Accuracy Evaluation of Three Systems for Self-monitoring of Blood Glucose With Three Different Test Strip Lots Following ISO 15197. J Diabetes Sci Technol (2014): Vol. 8(2) 422–424
http://dst.sagepub.com/content/8/2/422.long
Heinemann L, Freckmann G: A-/B-Blutzuckermesssysteme: Kommentar der Arbeitsgemeinschaft Diabetologische Technologie. Diabetologe (2014) 10:20–25· DOI 10.1007/s11428-013-1166-4
http://link.springer.com/article/10.1007%2Fs11428-013-1166-4
Thomas A, Heinemann L, Freckmann G: Auf dem Weg zum „Closed-loop“-System: Bestandteile und Schritte. Diabetologe (2014) 10:48–55· DOI 10.1007/s11428-013-1127-y
http://link.springer.com/article/10.1007/s11428-013-1127-y
Hessel F, Freckmann G, Resch A: Konsequenzen der Genauigkeit von Blutglucosemesssystemen: Klinische und ökonomische Aspekte. Diabetologe (2014) 10:26–35· DOI 10.1007/s11428-013-1124-1
http://link.springer.com/article/10.1007/s11428-013-1124-1
Heinemann L, Thomas A, Freckmann G: Diabetestechnologie. Diabetologe (2014) 10:11–12· DOI 10.1007/s11428-013-1122-3
http://link.springer.com/article/10.1007%2Fs11428-013-1122-3
Freckmann G: Kontinuierliche Glukosemessung und künstliches Pankreas. Diabetologie kompakt (5. Auflage), Heidelberg: Springer Medizin, 2014
Freckmann G: Blutzuckermessen: Warum die unterschiedlichen Einheiten?. Diabetes Ratgeber (2014) 11
Utz T, Braun M, Graichen K, Freckmann G: Model of the Glucose-Insulin System of Type-1 Diabetics and Optimization-based Bolus Calculation. 2014 UKACC International Conference on Control 9th - 11th July 2014, Loughborough, U.K
Thomas A, Freckmann G: ATTD: Ein relativ junger Kongress etabliert sich. Diabetes & Technologie (2014) 1
Freckmann G, Baumstark A, Schmid C, Pleus S, Link M, Haug C: Evaluation of 12 Blood Glucose Monitoring Systems for Self-Testing: System Accuracy and Measurement Reproducibility. Diabetes Technol Ther (2014) 16(2): 1-10
http://online.liebertpub.com/doi/abs/10.1089/dia.2013.0208
Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C: In Response to Teodorczyk and Coauthors: System Accuracy of Blood Glucose Monitoring Devices According to the Current and Proposed ISO 15197 Standards. J Diabetes Sci Technol (2013): 1659-1660
http://dst.sagepub.com/content/7/6/1659.long
Baumstark A, Schmid C, Pleus S, Haug C, Freckmann G: Influence of Partial Pressure of Oxygen in Blood Samples on Measurement Performance in Glucose-Oxidase-Based Systems for Self-Monitoring of Blood Glucose. J Diabetes Sci Technol (2013) Volume 7, Issue 6: 1513-1521
http://dst.sagepub.com/content/7/6/1513.long
Schmid C, Baumstark A, Pleus S, Haug C, Tesar M, Freckmann G: Impact of Partial Pressure of Oxygen in Blood Samples on the Performance of Systems for Self-Monitoring of Blood Glucose. Diabetes Technol Ther (2014) 16(3): 1-10
http://online.liebertpub.com/doi/abs/10.1089/dia.2013.0184
Schnell O, Hinzmann R, Kulzer B, Freckmann G, Erbach M, Lodwig V, Heinemann L: Assessing the Analytical Performance of Systems for Self-Monitoring of Blood Glucose: Concepts of Performance Evaluation and Definition of Metrological Key Terms. J Diabetes Sci Technol (2013) Volume 7, Issue 6: 1585-1594
http://dst.sagepub.com/content/7/6/1585.long
Schmid C, Haug C, Heinemann L, Freckmann G: System Accuracy of Blood Glucose Monitoring Systems: Impact of Use by Patients and Ambient Conditions. Diabetes Technol Ther (2013) Volume 15, Number 10
http://online.liebertpub.com/doi/abs/10.1089/dia.2013.0047
Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C: Partial Pressure of Oxygen in Capillary Blood Samples from the Fingertip. J Diabetes Sci Technol (2013): 1648-1649
http://dst.sagepub.com/content/7/6/1648.long
Zschornack E, Schmid C, Pleus S, Link M, Klötzer HM, Obermaier K, Schoemaker M, Strasser M, Frisch G, Schmelzeisen-Redeker G, Haug C, Freckmann G: Evaluation of the Performance of a Novel System for continuous Glucose Monitoring. J Diabetes Sci Technol (2013) 7(4): 815-823
http://dst.sagepub.com/content/7/4/815.long
Pleus S, Schmid C, Link M, Zschornack E, Klötzer HM, Haug C, Freckmann G: Performance Evaluation of a Continuous Glucose Monitoring System under Conditions Similar to Daily Life. J Diabetes Sci Technol (2013) 7(4): 833-841
http://dst.sagepub.com/content/7/4/833.long
Freckmann G, Pleus S, Link M, Zschornack E, Klötzer HM, Haug C: Performance Evalution of Three Continuous Glucose Monitoring Systems: Comparison of Six Sensors per Subject in Parallel. J Diabetes Sci Technol (2013) 7(4): 842-853
http://dst.sagepub.com/content/7/4/833.long
Liebl A, Henrichs HR, Heinemann L, Freckmann G, Biermann E, Thomas A: Continuos Glucose Monitoring: Evidence and Consensus Statement for Clinical Use. J Diabetes Sci Technol (2013) 7(2): 500-519
http://dst.sagepub.com/content/7/2/500.long
Heinemann L, Freckmann G, Koschinsky T: Considerations for an Institution for Evaluation of Diabetes Technology Devices to Improve Their Quality in the European Union. J Diabetes Sci Technol (2013) 7(2): 542-547
http://dst.sagepub.com/content/7/2/542.long
Patte C, Pleus S, Wiegel C, Schiltges G, Jendrike N, Haug C, Freckmann G: Effect of Infusion Rate and Indwelling Time on Tissue Resistance Pressure in Small-Valume Subcutaneous Infusion like in Continuous Subcutaneous Insulin Infusion. Diabetes Technol Ther (2013) 15(4): 1-6
http://www.liebertonline.com/doi/pdf/10.1089/dia.2010.0064
Freckmann G., Kraatz, K.: In der Tradition der "Ulmer Zuckeruhr". Diabetes & Technologie (2013) 3+4: 18-20
Freckmann G, Link M: Darauf sollten Patienten bei der Selbstmessung achten: Blutzuckermessgeräte richtig anwenden. Heilberufe / Das Pflegemagazin (2013) 65 (11):2-4
Freckmann G, Link M: Moderne Blutzuckermessgeräte
Patientensicherheit/ISO Norm. Forum Sanitas - Das informative Medizinmagazin 2013 (3): 15-17
Freckmann G: Neues Messgerät - höhere Zuckerwerte?. Diabetes Ratgeber (2013) 2: 51
Liebl A, Henrichs HR, Heinemann L, Freckmann G, Biermann E, Thomas A: Evidenz und Konsens für den klinischen Einsatz von CGM. Diabetes, Stoffwechsel und Herz, Heft 1, 2012 (21) : 32-47
http://www.ds-herz.de
Baumstark A, Pleus S, Schmid C, Link M, Haug C, Freckmann G: Lot-to-Lot Variability of Test Strips and Accuracy Assessment of Systems for Self-Monitoring of Blood Glucose according to ISO 15197. J Diabetes Sci Technol (2012) 6(5): 1076-1086
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C: System Accuracy Evaluation of 43 Blood Glucose Monitoring Systems for Self-Monitoring of Blood Glucose according to DIN EN ISO 15197. J Diabetes Sci Technol (2012) 6(5): 1060-1075
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Patte C, Pleus S, Galley P, Weinert S, Haug C, Freckmann G: Feasibility of Overnight Closed-Loop Control Based on Hourly Blood Glucose Measurements. J Diabetes Sci Technol (2012) 6(4): 902-909
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Freckmann G, Pleus S, Haug C, Bitton G, Nagar R: Increasing Local Blood Flow by Warming the Application Site: Beneficial Effects on Postprandial Glycemic Excursions. J Diabetes Sci Technol (2012) 6(4): 780-785
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Freckmann G, Schmid C, Ruhland K, Baumstark A, Haug C: Integrated Self-Monitoring of Blood Glucose System: Handling Step Analysis. J Diabetes Sci Technol (2012) 6(4): 938-946
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Heinemann L, Lodwig V, Freckmann G: Accuracy in blood glucose measurement: What will a tightening of requirements yield?. J Diabetes Sci Technol (2012) 6(2): 435-443
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Freckmann G, Pleus S, Westhoff A, Krinelke L, Buhr A, Jendrike N, Haug C: Clinical Performance of a device that applies local heat to the insulin infusion site: a crossover study. J Diabetes Sci Technol (2012) 6(2): 320-327
http://www.journalofdst.org/May2012/Abstracts/VOL-6-2-ORG3- OCVIRK-abstract.pdf
Freckmann G: Vertrauen ist gut, Kontrolle ist besser. MedizinProdukt (2012) 5: 14
Freckmann G, Schmid C: Zuverlässige Blutzuckerwerte. Diabetes & Technologie (2012) 3: 15-16
http://www.diabetes-und-technologie.de
Freckmann G, Link M: Blutzuckermessgeräte - Darauf sollten Patienten bei der Selbstmessung achten. Der Hausarzt (2012) 1: 48-50
Freckmann G., Kraatz, K.: Closed-Loop-System - die erste Erfindung. Diabetes & Technologie 2012 (1): 22-23
http://www.diabetes-und-technologie.de
Heinemann L, Freckmann G: Genauigkeit bei der Blutglukosemessung Was bringt eine Verschärfung der Anforderungen?. Kompendium Diabetes 6. Jahrg. 2011
Freckmann G., Haug C., Heinemann L.: Blutzuckerselbstmessung heute: Sind alle Geräte gleich?. Diabetes, Stoffwechsel und Herz, Heft 4, 2011 (20) : 235-241
http://www.ds-herz.de
Freckmann G, Heinemann L: Experten im Dialog. Diabetes & Technologie 2011 (2): 10 - 11
http://www.diabetes-und-technologie.de
Thomas A, Freckmann G, Heinemann L: Diskussionen über Diabetestechnologie. Diabetes & Technologie 2011 (1): 24-25
http://www.diabetes-und-technologie.de
Freckmann G: Mit Wärme Insulin beschleunigen. Diabetes & Technologie 2011 (1): 31
http://www.diabetes-und-technologie.de
Freckmann G.: Schmerz beim Stechen: Wie groß ist er?. Diabetes & Technologie 2011 (1): 22-23
http://www.diabetes-und-technologie.de
Zisser H, Wagner R, Pleus S, Haug C, Jendrike N, Parkin C, Schweitzer M, Freckmann G: Clinical Performance of Three Bolus Calculators in Subjects with Type 1 Diabetes Mellitus: A Head-to-Head-to-Head Comparison. Diabetes Technol Ther (2010) 12(12): 955-961
http://www.liebertonline.com/doi/pdf/10.1089/dia.2010.0064
Freckmann G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, Heister F, Haug C: System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197. Diabetes Technol Ther (2010) 12(3): 221-231
http://www.liebertonline.com/doi/abs/10.1089/dia.2009.0128
Freckmann G: Diabetesmanagement früher und heute. FAZ Verlagsbeilage (2010) Nr. 252: B5
Freckmann G, Baumstark A: Blutzuckermessung und Messgeräte heute: Winzige Tropfen, weniger Schmerz, mehr Funktion!. Diabetes-Journal (2010) 59(9): 15-21
http://www.diabetes-journal.de/index.php?id=5188&tx_n98kirchheimarchiv_pi1[search]=%22blutzuckermessung+und+messger%C3%A4te+heute%22&tx_n98kirchheimarchiv_pi1[year]=2010&tx_n98kirchheimarchiv_pi1[page]=&tx_n98kirchheimarchiv_pi1[showDetail]=17804&tx_n98ki
Baumstark A, Freckmann G: Messwertabweichungen CE-Markierung von Blutzuckermessgeräten. JATROS Diabetes & Stoffwechsel (2010) 13(3): 30-31
http://endokrinologie.universimed.com/artikel/messwertabweichungen-ce-markierung-von-blutzuckermessger%C3%A4ten
Nielsen JK, Freckmann G, Kapitza C, Ocvirk G, Koelker KH, Kamecke U, Gillen R, Amann-Zalan I, Jendrike N, Christiansen JS, Koschinsky T, Heinemann L: Glucose monitoring by microdialysis: performance in a multicentre study. Diabet Med (2009) 26(7): 714-721
http://www3.interscience.wiley.com/journal/122372002/abstract$
Henrichs HR, Liebl A, Reichel A, Quester W, Freckmann G, Fach EM, Thomas A: Experimentelle Untersuchungen und klinische Evidenz der Insulinpumpentherapie (CSII). Diabetologie (2009) 4: 390-397
http://dx.doi.org/10.1055/s-0029-1224715
Ocvirk G, Hajnsek M, Gillen R, Guenther A, Hochmuth G, Kamecke U, Koelker K, Kraemer P, Obermaier K, Reinheimer C, Jendrike N, Freckmann G: The Clinical Research Tool: A High-Performance Microdialysis-Based System for Reliably Measuring Interstitial Fluid Glucose Concentration. J Diabetes Sci Technol (2009) 3(3): 468-477
http://www.journalofdst.org/May2009/Abstracts/VOL-3-3-ORG3- OCVIRK-abstract.pdf
Freckmann G: Genauigkeit von Blutzuckermessgeräten. Diabetes & Technologie (2009): 26-27
Heinemann L, Freckmann G: Diabetes-Technologie: Nutzen für den Patienten und den Diabetologen. Diabetes-Congress-Report 5(2009): 14-17
Freckmann G: Blutzuckerwerte: Präzise, richtig, genau. feelfree 3 (2009) von DiaExpert: 20-21
Freckmann G: Closed Loop: Wird es eine künstliche Bauchspeicheldrüse geben?. feelfree 3 (2009) von DiaExpert: 8-10
Freckmann G, Jovanovic L, Baumstark A, Haug C, van der Helm W: The CIRCADIAN Study: Get-up Phenomenon in type 1 diabetes. Diabetes Care (2008) 31(11): e85
http://care.diabetesjournals.org/content/31/11/e85.extract
Zick R, Petersen B, Richter M, Haug C: On behalf of the SAFIR Study Group: Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther (2007) 9(6): 483-492
http://www.liebertonline.com/doi/pdfplus/10.1089/dia.2007.0230
Freckmann G, Hagenlocher S, Baumstark A, Jendrike N, Gillen RC, Rössner K, Haug C: Continuous subcutaneous tissue glucose profiles in healthy subjects under everyday life conditions and after different meals. J Diabetes Sci Technol (2007) 1(5): 695-703
http://www.journalofdst.org/September2007/pdf/VOL-1-5-ORG3- FRECKMANN.pdf
Freckmann G: Was bringt die Zukunft?. Diabetiker Ratgeber (2007) 3: 20-21
Freckmann G, Pfeiffer AFH: Kontinuierliche Glucosemessung und Künstliches Pankreas. In: Diabetologie kompakt 4 te Auflage (2006), Thieme-Verlag
http://thieme.ciando.com/shop/book/bookmarks/index.cfm/fuseaction/bookmarks/bok_id/13861/cat_id/0/cat_nav/0
Freckmann G: Zuckermessung am laufenden Band. Neue Apotheken Illustrierte (2006): 32-33
Freckmann G, Pfeiffer AFH: Kontinuierliche Glucosemessung und Künstliches Pankreas. In: Diabetologie kompakt 3 te Auflage (2004)
Freckmann G: Biostator Oder: Die Entwicklung der künstlichen Bauchspeicheldrüse. Patientenzeitschrift ???
Hoss U, Kalatz B, Gessler R, Pfleiderer HJ, Andreis E, Rutschmann M, Rinne H, Schoemaker M, Haug C, Fußgänger RD: A novel method for continuous online glucose monitoring in humans: the comparative microdialysis technique. Diabetes Technol Ther (2001) 3(2): 237-243
http://www.ncbi.nlm.nih.gov/pubmed/11478331
Freckmann G, Kalatz B, Pfeiffer B, Hoss U, Haug C: Recent advances in continuous glucose monitoring. Exp Clin Endocrinol Diabetes Suppl. 2 (2001) 109: S347-S357
Hoss U, Gessler R, Sternberg F, Salgado M, Fußgänger R: Continuous glucose monitoring and automated insulin infusion. Biocybernetics and Biomedical Engineering (1999) 19(2): 69-76
Sternberg F, Hoss U, Salgado M, Pfeiffer EF: Self-monitoring of blood glucose compared with continuous tissue glucose measurement. Diabetes Care (1997) 20(7): 1208-1209
Pfeiffer EF: Vom künstlichen endokrinen Pankreas zum implantierbaren Glukosensor: Kontinuierliches s.k. Glukose-Monitoring.. Diabetes und Stoffwechsel (1996) 5: 215-222
Sternberg F, Meyerhoff C, Mennel FJ, Mayer H, Bischof F, Pfeiffer EF: Does fall in tissue glucose precede fall in blood glucose?. Diabetologia (1996) 39(5): 609-612
http://www.springerlink.com/content/q4pg36p71414216h/?p=2df442a9f5e140099509fe7388505e36&pi=13
Pfeiffer EF: [Glucose sensors in tissue, glucose monitoring and controlled insulin administration]. Med Klin Suppl. 1 (1996) 91: 12-15
Meyerhoff C, Mennel FJ, Sternberg F, Hoss U, Pfeiffer EF: Current status of the glucose sensor. The Endocrinologist (1996) 6(1): 51-58
http://journals.lww.com/theendocrinologist/Abstract/1996/01000/Current_Status_of_the_Glucose_Sensor.8.aspx
Meyerhoff C, Pfeiffer EF: Glukosesensoren für die Diabetes-Therapie: Stand der Technik. Klinikarzt (1995) 9: 446-452
Sternberg F, Meyerhoff C, Mennel FJ, Bischof F, Pfeiffer EF: Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring.. Diabetes Care (1995) 18(9): 1266-1269
http://care.diabetesjournals.org/content/18/9/1266.abstract
Sternberg F, Meyerhoff C, Mennel FJ, Bischof F, Mayer H, Schmidt R, Pfeiffer EF: Hypoglycemia detection combining glucosensor with microdialysis in IDDM. In: Baba S, Kaneko T, editors. Diabetes. (1995) Elsevier Science B.V., 1133-1137
Meyerhoff C, Bischof F, Pfeiffer EF: Long-term experiences with a computerized diabetes management and glucose monitoring system in insulin-dependent diabetic patients. Diabetes Res Clin Pract (1994) 24(1): 1-7
Sternberg F, Meyerhoff C, Mennel FJ, Bischof F, Mayer H, Pfeiffer EF: Comments on subcutaneous glucose monitoring. Diabetologia (1994) 37(5): 540-542
http://www.springerlink.com/content/f63wh52hq6745731/?p=1d88e5cb2b4d45658c2361498aceeed0&pi=15
Bischof F, Meyerhoff C, Pfeiffer EF: Quality control of intensified insulin therapy: HbA1 versus blood glucose. Horm Metab Res (1994) 26(12): 574-578
http://www.unboundmedicine.com/medline/ebm/record/7705761/abstract/Quality_control_of_intensified_insulin_therapy:_HbA1_versus_blood_glucose_
Meyerhoff C, Mennel FJ, Bischof F, Sternberg F, Pfeiffer EF: Combination of microdialysis and glucose sensor for continuous on line measurement of the subcutaneous glucose concentration: theory and practical application. Horm Metab Res (1994) 26(11): 538-543
http://www.unboundmedicine.com/medline/ebm/record/7875650/abstract/Combination_of_microdialysis_and_glucose_sensor_for_continuous_on_line_measurement_of_the_subcutaneous_glucose_concentration:_theory_and_practical_application_
Sternberg F, Meyerhoff C, Mennel FJ, Hoss U, Mayer H, Bischof F, Pfeiffer EF: Calibration problems of subcutaneous glucosensors when applied "in-situ" in man. Horm Metab Res (1994) 26(11): 523-525.
http://www.unboundmedicine.com/medline/ebm/record/7875646/abstract/Calibration_problems_of_subcutaneous_glucosensors_when_applied_%22in_situ%22_in_man_
Pfeiffer EF: The "Ulm Zucker Uhr System" and its consequences. Horm Metab Res (1994) 26(11): 510-514
http://www.unboundmedicine.com/medline/ebm/record/7875644/abstract/the_%22Ulm_Zucker_Uhr_System%22_and_its_consequences_
Meyerhoff C: Gewichtsreduktion steht am Anfang. Therapiewoche (1994) 44(28): 1608-1613
Bischof F: Vertrauen ist gut, Kontrolle notwendig. Therapiewoche (1994) 44(28): 1602-1606
Kerner W, Kiwit M, Linke B, Keck FS, Zier H, Pfeiffer EF: The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron 8(9-10): 473-482
Meyerhoff C, Bischof F, Mennel FJ, Sternberg F, Bican J, Pfeiffer EF: On line continuous monitoring of blood lactate in men by a wearable device based upon an enzymatic amperometric lactate sensor. Biosens Bioelectron 8(9-10): 409-414
Meyerhoff C, Sternberg F, Bischof F, Mennel FJ, Pfeiffer EF: Measurement of subcutaneous glucose concentration. Diabetes Care (1993) 16(12): 1626-1628
http://care.diabetesjournals.org/content/16/12/1626.short
Pfeiffer EF, Meyerhoff C, Bischof F, Keck FS, Kerner W: On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res (1993) 25(2): 121-124
http://www.unboundmedicine.com/medline/ebm/record/8458608/abstract/On_line_continuous_monitoring_of_subcutaneous_tissue_glucose_is_feasible_by_combining_portable_glucosensor_with_microdialysis_
Pfeiffer EF: Artificial pancreas, glucose sensors and the impact upon diabetology. Int J Artif Organs (1993) 16(9): 636-644
Meyerhoff C, Bischof F, Mennel FJ, Sternberg F, Pfeiffer EF: Use of the microdialysis technique in the monitoring of subcutaneous tissue glucose concentration. Int J Artif Organs (1993) 16(5): 268-275
Sternberg F, Meyerhoff C, Mennel FJ, Bischof F, Pfeiffer EF: Thema: Gewebsglukose-Bestimmung. Unabhängige Methode zur Bestimmung der Glukosekonzentration im s.k. Gewebe- Basis für die Kalibrierung des Glukosesensors.. Der Kassenarzt (1993) 33(46): 38-40
Pfeiffer EF: Wie weit sind wir vom implantierbaren Glucosensor?. Dtsch Arztebl Int (1993) 90: 2325-2331
Duntas L, Keck FS, Haug C, Hetzel W, Wolf CF, Rosenthal J, Pfeiffer EF: Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1992) 16(3): 203-208
Dolderer M, De la Fuente A, Kerner W, Zier H, Pfeiffer EF: Continuous blood glucose measurement and insulin levels in subjects with ideal body weight, normal body weight, non-diabetic overweight and obese subjects with impaired glucose tolerance. Horm Metab Res Suppl. 1 (1992) 26: 24-27
http://www.unboundmedicine.com/medline/ebm/record/1490688/full_citation/Continuous_blood_glucose_measurement_and_insulin_levels_in_subjects_with_ideal_body_weight_normal_body_weight_non_diabetic_overweight_and_obese_subjects_with_impaired_glucose_toleranc
Bischof F, Pfeiffer EF: Experiences with a computerized diabetes information system. Horm Metab Res Suppl. 1 (1992) 26: 146-148
http://www.unboundmedicine.com/medline/ebm/record/1490684/abstract/Experiences_with_a_computerized_diabetes_information_system_
Pfeiffer EF: Impact of insulin research upon biomedicine and clinical investigation. Horm Metab Res Suppl. 1 (1992) 26: 1-12
http://www.unboundmedicine.com/medline/ebm/record/1490669/full_citation/Impact_of_insulin_research_upon_biomedicine_and_clinical_investigation_
Pfeiffer EF: Störungen der Signalaussendung als Krankheitsfaktor am Beispiel endokriner Krankheiten. Jung-Stiftung für Wissenschaft und Forschung. 4: 47-68 (1992) Stuttgart-New York
Bischof F, Pfeiffer EF: Der Altersdiabetes - die negierte Krankheit, ihre Weggenossen und die Folgen. Münch med Wschr (1992) 134: 596-600
Keck FS, Kerner W, Meyerhoff C, Zier H, Pfeiffer EF: Characteristics and application of a continuous glucose registration device using the microdialysis technique. In: Scheller F, Schmid RD, editors. Biosensors: Fundamentals, technologies and applications (1992) Weinheim: VCH-Verlag 375-378
Zier H, Keck FS, Meyerhoff C, Kerner W, Bischof F, Pfeiffer EF: The continuous measurement of metabolic parameters with electrochemical sensors. In: Scheller F, Schmid RD, editors. Biosensors: Fundamentals, Technologies and Applications (1992) Weinheim: VCH: 369-373
Keck FS, Meyerhoff C, Kerner W, Siegmund T, Zier H, Pfeiffer EF: Combination of microdialysis and glucosensor permits continuous (on line) sc glucose monitoring in a patient operated device. II. Evaluation in animals.. Horm Metab Res (1992) 24(10): 492-493
http://www.unboundmedicine.com/medline/ebm/record/1464417/abstract/Combination_of_microdialysis_and_glucosensor_permits_continuous__on_line__SC_glucose_monitoring_in_a_patient_operated_device__II__Evaluation_in_animals_
Meyerhoff C, Bischof F, Sternberg F, Zier H, Pfeiffer EF: On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia (1992) 35(11): 1087-1092
http://www.springerlink.com/content/u044265617868v2w/?p=b80d100f290c492ca3424639ebae72c8&pi=11
Kerner W, Pfeiffer EF: The artificial pancreas-applications, problems, and promises. In: Samols E, editor. (1992) The Endocrine Pancreas. New York: Raven Press Ltd.: 441-456
Pfeiffer EF: The artificial pancreas. In: Rifkin H, Colwell JA, Taylor SI, editors. Diabetes 1991. (1991) Elsevier Science Publishers B.V.: 919-35
Keck FS, Kerner W, Meyerhoff C, Zier H, Pfeiffer EF: Combination of microdialysis and Glucosensor permits continuous (on line) s.c. glucose monitoring in a patient operated device: I. In vitro evaluation.. Horm Metab Res (1991) 23(12): 617-618
http://www.unboundmedicine.com/medline/ebm/record/1778599/abstract/Combination_of_microdialysis_and_Glucosensor_permits_continuous__on_line__s_c__glucose_monitoring_in_a_patient_operated_device:_I__In_vitro_evaluation_
Zier H, Kerner W, Brueckel J, Pfeiffer EF: ["Glucosensor Unitec Ulm": A portable, continuously measuring glucose sensor and monitor].. Biomed Technik (1990) 35(1-2): 2-4
Kerner W, Keck FS, Pfeiffer EF: [Modern methods for the regulation of type 1 diabetes?]. Dtsch Med Wochenschr (1990) 115(43): 1653
Brueckel J, Zier H, Kerner W, Pfeiffer EF: Progress in practical endocrinology. The Glucosensor Unitec Ulm-a portable monitor for continuous blood glucose measurement.. Horm Metab Res (1990) 22(7): 382-384
http://www.unboundmedicine.com/medline/ebm/record/2401447/abstract/Progress_in_practical_endocrinology__The_Glucosensor_Unitec_Ulm__a_portable_monitor_for_continuous_blood_glucose_measurement_
Pfeiffer EF: The glucose sensor: the missing link in diabetes therapy. Horm Metab Res Suppl. 1 (1990) 24: 154-164
http://www.unboundmedicine.com/medline/ebm/record/2272621/abstract/The_glucose_sensor:_the_missing_link_in_diabetes_therapy_
Keck FS, Pfeiffer EF: The first experimental diabetes mellitus. Acta Diabetol Lat (1989) 26(1): 79-81
http://www.springerlink.com/content/a2037q26718033u4/?p=879ea2d9a7e3446da8addcf0d1ede0f5&pi=9
Pfeiffer EF: Physiologische Hormonsubstitution als realistisches Therapieziel. Dtsch Arztebl Int (1989) 86: 2164-2168
Dolderer M, De la Fuente A, Kerner W, Zier H, Pfeiffer EF: Continuous blood glucose measurement and insulin levels in subjects with ideal body weight, normal body weight, overweight and impaired glucose tolerance. Eur J Clin Invest (1989) 19: A69
Brueckel J, Kerner W, Zier H, Steinbach G, Pfeiffer EF: In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr (1989) 67(9): 491-495
Kerner W, Bruckel J, Zier H, Arias P, Thun C, Moncayo R, Pfeiffer EF: Similar effects of pulsatile and constant intravenous insulin delivery. Diabetes Res Clin Pract (1988) 4(4): 269-274
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T5Y-4HM8NJJ-4&_user=2532525&_coverDate=04%2F06%2F1988&_rdoc=4&_fmt=high&_orig=browse&_srch=doc-info(%23toc%235015%231988%23999959995%23611511%23FLP%23display%23Volume)&_cdi=5015&_sort=d&_docanchor
Kerner W, Zier H, Steinbach G, Bruckel J, Pfeiffer EF, Weiss T, Cammann K, Planck H: A potentially implantable enzyme electrode for amperometric measurement of glucose. Horm Metab Res Suppl. 1 (1988) 20: 8-13
http://www.unboundmedicine.com/medline/ebm/record/3248792/abstract/A_potentially_implantable_enzyme_electrode_for_amperometric_measurement_of_glucose_
Kerner W, Wallmuller G, Beischer W, Pfeiffer EF: Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII. Horm Metab Res Suppl. 1 (1988) 18: 74-77
http://www.unboundmedicine.com/medline/ebm/record/3056816/abstract/Substitution_of_basal_delivery_of_insulin_by_proinsulin_in_type_I_diabetic_patients_under_CSII_
Pfeiffer EF: Artificial pancreas: state of the art. Int J Artif Organs (1988) 11(1): 13-26
Pfeiffer EF: Artificial endocrine pancreas (closed-loop-system for blood sugar control in diabetes mellitus): introduction to the subject. Int J Artif Organs (1988) 12(4): 310-319
Pfeiffer EF, Kerner W: The artificial endocrine pancreas. DIAMET (1987) 16: 1-5
Kerner W, Pfeiffer EF: Effects of proinsulin on carbohydrate metabolism in diabetes mellitus. N Engl J Med (1987) 317(10): 632-633
Pfeiffer EF: On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. Diabetologia (1987) 30(2): 51-65
http://www.springerlink.com/content/x546v1k3467525u8/?p=5f8dfb7f332542148143c9bf38a6cd8e&pi=0
Arias P, Kerner W, Zier H, Navascues I, Pfeiffer EF: Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care (1995) 8(2): 134-140
http://care.diabetesjournals.org/content/8/2/134.abstract
Pfeiffer EF, Kerner W: Use of artificial pancreas and portable insulin infusion pumps in diabetes therapy: past, present, and future. Int J Artif Organs (1985) 9(2): 129-137
Pfeiffer EF, Kerner W: [The artificial endocrine pancreas and insulin pumps: past, present and future]. Bull Mem Acad R Med Belg (1984) 139(2): 177-187
Kerner W, Navascues I, Torres AA, Pfeiffer EF: Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism (1984) 33(5): 458-464
http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6WN4-4CBVMWF-M5-1&_cdi=6952&_user=2532525&_pii=0026049584901483&_orig=browse&_coverDate=05%2F31%2F1984&_sk=999669994&view=c&wchp=dGLbVIb-zSkzk&md5=b4245c3c227668c48f55f2fb2732191c&ie=/sdarticle.pdf
Stapelfeldt W, Bender H, Schusdziarra V, Pfeiffer EF: Effect of continuous and oscillatory portal vein insulin infusion upon glucose-induced insulin release in rats. Res Exp Med (1984) 184(1): 67-71
Kerner W, Pfeiffer EF: Das künstliche Pankreas. Seine Bedeutung für Theorie und Praxis der Diabetes-Behandlung.. Schwerpunktmed (1984) 7: 19-28
Pfeiffer EF, Kerner W: Diabetestherapie: Künstliches endokrines Pankreas und Insulinpumpen. Dtsch Arztebl (1984) 47 Sonderdruck: 1-9
Kerner W, Beischer W, Navascues I, Merkle P, Pfeiffer EF: Continuous blood glucose measurement and glucose-controlled dextrose infusion in diagnosis and treatment of organic hyperinsulinism. Artificial systems for insulin delivery (1983): 549-554
Pfeiffer EF: Insulinpumpen für jeden Typ-I-Diabetiker?. Ärztliche Praxis (1983) 35: 126-129
Pfeiffer EF, Kerner W: The use of artificial pancreas and portable insulin infusion pumps in diabetes therapy:the past, present, and future. Progress in Artif Organs (1983): 31-39
Pfeiffer EF, Kerner W: Comparison of the ability of glucose-controlled and preprogrammed insulin delivery systems to achieve normoglycemia. In: Brunnetti P., editor. Artificial Sytems for Insulin Delivering. (1983) Raven Press: 573-583
Kerner W, Rosak C, Navascues I, Althoff PH, Torres A, Jungmann E, Zier H, Schöffling K, Pfeiffer EF, Plischke W, Storz G: [A new test-strip for checking blood-sugar levels]. Dtsch Med Wochenschr (1982) 107(36): 1346-1349
Kerner W, Schultz M, Schock D, Pfeiffer EF: Variations of insulin requirements in insulin dependent diabetics for meals taken at different times of the day. Horm Metab Res Suppl. 1 (1982) 12: 228-230
Pfeiffer EF: The artificial endocrine pancreas (AEP): past, presence and future. Horm Metab Res Suppl. 1 (1982) 12: 187-201
http://www.unboundmedicine.com/medline/ebm/record/6386079/full_citation/%5BThe_artificial_endocrine_pancreas_and_insulin_pumps:_past_present_and_future%5D
Klier M, Kerner W, Torres AA, Pfeiffer EF: Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Diabetes Care (1981) 4(2): 193-195
http://care.diabetesjournals.org/content/4/2/193.abstract
Navascués I, Kerner W, Meissl M, Pfeiffer EF: Effect of acarbose on blood glucose control and insulin requirements in insulin-dependent diabetics assessed by the artificial pancreas. Int Congr Ser (1981) 594: 455-459
http://www1.elsevier.com/homepage/sab/ics/doc/publications.html
Pfeiffer EF, Kerner W: The artificial endocrine pancreas: its impact on the pathophysiology and treatment of diabetes mellitus. Diabetes Care (1981) 4(1): 11-26
http://care.diabetesjournals.org/content/4/1/11.short
Ozyol MB, Herfarth C, Kerner W, Pfeiffer EF: [Postoperative blood-sugar regulation in pancreatectomized patients using the artificial "beta cell"]. Chirurg (1979) 50(4): 227-232
Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF: The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics. Horm Metab Res Suppl. 1 (1979) 8: 93-96
http://www.unboundmedicine.com/medline/ebm/record/395097/abstract/The_effect_of_three_days_of_blood_glucose_normalization_by_means_of_an_%22artificial_endocrine_pancreas%22_on_the_concentrations_of_growth_hormone_glucagon_and_cortisol_in_juvenile_diabetic
Pfeiffer EF, Meissner C, Beischer W, Kerner W, Lefebvre PJ, Raptis S, Tamas G Jr Metabolism (1978) 27(9 Suppl. 1): 1415-1426
http://www.unboundmedicine.com/medline/ebm/record/355785/full_citation/Antidiabetic_action_of_somatostatin_assessed_by_artificial_beta_cell_
Pfeiffer EF, Kerner W: Das künstliche endokrine Pankreas in Experiment und Klinik. Dtsch Arztebl (1987) 10 Sonderdruck: 547-554
Kerner W, Beischer W, Tamas G Jr, Raptis S, Pfeiffer EF: [Insulin treatment of decompensated diabetes mellitus with a new artificial endocrine pancreas (author's transl)]. Dtsch Med Wochenschr (1977) 102(42): 1500-1505
Pfeiffer EF, Beischer W, Kerner W: The artificial endocrine pancreas in clinical research. Horm Metab Res Suppl 7 (1977) 9: 95-112
http://www.unboundmedicine.com/medline/ebm/record/406185/full_citation/The_artificial_endocrine_pancreas_in_clinical_research_
Kerner W, Thum C, Tamas G, Beischer W, Clemens AH, Pfeiffer EF: Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res (1976) 8(4): 256-261
http://www.unboundmedicine.com/medline/ebm/record/783030/abstract/Attempts_at_perfect_normalization_of_glucose_tolerance_test_of_severe_diabetics_by_artificial_beta_cell_
Meissner C, Thum C, Beischer W, Winkler G, Schroder KE, Pfeiffer EF: Antidiabetic action of somatostatin-assessed by the artificial pancreas. Diabetes (1975) 24(11): 988-996
http://diabetes.diabetesjournals.org/content/24/11/988.abstract
Pfeiffer EF, Thum C, Clemens AH: The artificial beta cell - a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res (1974) 6(5): 339-342
http://www.unboundmedicine.com/medline/ebm/record/4607598/full_citation/The_artificial_beta_cell__a_continuous_control_of_blood_sugar_by_external_regulation_of_insulin_infusion__glucose_controlled_insulin_infusion_system__
Pfeiffer EF, Thum C: [The artificial beta-cell. An automatic regulated insulin-infusion-system for diabetics]. Naturwissenschaften (1974) 61(10): 455-456